Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.
2.

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.

Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG.

Ann Emerg Med. 2007 Apr;49(4):391-402, 402.e1-2. Epub 2006 Sep 29.

PMID:
17011666
3.

Progesterone for acute traumatic brain injury.

Ma J, Huang S, Qin S, You C, Zeng Y.

Cochrane Database Syst Rev. 2016 Dec 22;12:CD008409. doi: 10.1002/14651858.CD008409.pub4. Review.

PMID:
28005271
4.

Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma.

Shakeri M, Boustani MR, Pak N, Panahi F, Salehpour F, Lotfinia I, Meshkini A, Daghighi S, vahedi P, Khani M, Taghiloo D.

Clin Neurol Neurosurg. 2013 Oct;115(10):2019-22. doi: 10.1016/j.clineuro.2013.06.013. Epub 2013 Jul 18.

PMID:
23871679
5.

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW.

JAMA. 1996 Aug 21;276(7):538-43.

PMID:
8709402
6.

Very early administration of progesterone for acute traumatic brain injury.

Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG; NETT Investigators..

N Engl J Med. 2014 Dec 25;371(26):2457-66. doi: 10.1056/NEJMoa1404304. Epub 2014 Dec 10.

7.

Progesterone for acute traumatic brain injury.

Ma J, Huang S, Qin S, You C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008409. doi: 10.1002/14651858.CD008409.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 22;12 :CD008409.

PMID:
23076947
9.

A clinical trial of progesterone for severe traumatic brain injury.

Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators..

N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10.

10.

The effect of age on functional outcome in mild traumatic brain injury: 6-month report of a prospective multicenter trial.

Mosenthal AC, Livingston DH, Lavery RF, Knudson MM, Lee S, Morabito D, Manley GT, Nathens A, Jurkovich G, Hoyt DB, Coimbra R.

J Trauma. 2004 May;56(5):1042-8.

PMID:
15179244
11.

Therapeutic temperature modulation in severe or moderate traumatic brain injury: a propensity score analysis of data from the Nationwide Japan Neurotrauma Data Bank.

Miyata K, Ohnishi H, Maekawa K, Mikami T, Akiyama Y, Iihoshi S, Wanibuchi M, Mikuni N, Uemura S, Tanno K, Narimatsu E, Asai Y.

J Neurosurg. 2016 Feb;124(2):527-37. doi: 10.3171/2015.3.JNS141895. Epub 2015 Sep 18.

PMID:
26381247
12.

Progesterone for acute traumatic brain injury.

Junpeng M, Huang S, Qin S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008409. doi: 10.1002/14651858.CD008409.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD008409.

PMID:
21249708
13.

Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.

Presneill J, Little L, Nichol A, French C, Cooper DJ, Haddad S, Duranteau J, Huet O, Skrifvars M, Arabi Y, Bellomo R; EPO-TBI Investigators.; ANZICS Clinical Trials Group..

Trials. 2014 Dec 20;15:501. doi: 10.1186/1745-6215-15-501.

14.

Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.

Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, Härtl R.

J Neurosurg. 2015 Jan;122(1):202-10. doi: 10.3171/2014.10.JNS132545. Erratum in: J Neurosurg. 2016 Jan;124(1):277.

PMID:
25380107
15.

Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.

Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, Pandharipande PP.

Trials. 2012 Sep 26;13:177. doi: 10.1186/1745-6215-13-177.

16.

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.

Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N; Pharmos TBI investigators..

Lancet Neurol. 2006 Jan;5(1):38-45.

PMID:
16361021
17.

Dosing and safety of cyclosporine in patients with severe brain injury.

Hatton J, Rosbolt B, Empey P, Kryscio R, Young B.

J Neurosurg. 2008 Oct;109(4):699-707. doi: 10.3171/JNS/2008/109/10/0699.

18.

Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4.

Fulkerson DH, White IK, Rees JM, Baumanis MM, Smith JL, Ackerman LL, Boaz JC, Luerssen TG.

J Neurosurg Pediatr. 2015 Oct;16(4):410-9. doi: 10.3171/2015.3.PEDS14679. Epub 2015 Jul 3.

PMID:
26140392
19.

Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy.

Narotam PK, Morrison JF, Nathoo N.

J Neurosurg. 2009 Oct;111(4):672-82. doi: 10.3171/2009.4.JNS081150.

PMID:
19463048

Supplemental Content

Support Center